Ciencias de la Salud
Área
University of Turin
Turín, ItaliaPublicacións en colaboración con investigadores/as de University of Turin (17)
2024
-
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
Neuro-oncology, Vol. 26, Núm. 9, pp. 1723-1737
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
2022
-
Providing Spiritual Care to In-Hospital Patients During COVID-19: A Preliminary European Fact-Finding Study
Journal of Religion and Health, Vol. 61, Núm. 3, pp. 2212-2232
2021
-
Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT
American Journal of Hematology, Vol. 96, Núm. 5, pp. 571-579
2020
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639
2017
-
Early postnatal genistein administration permanently affects nitrergic and vasopressinergic systems in a sex-specific way
Neuroscience, Vol. 346, pp. 203-215
2016
-
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
HIV Medicine, Vol. 17, Núm. 6, pp. 471-478
2014
-
Perinatal exposure to genistein affects the normal development of anxiety and aggressive behaviors and nitric oxide system in CD1 male mice
Physiology and Behavior, Vol. 133, pp. 107-114
2012
-
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting
Therapeutic Drug Monitoring, Vol. 34, Núm. 2, pp. 232-235
2011
-
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction
Journal of Infectious Diseases, Vol. 204, Núm. 1, pp. 145-153
-
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: The ARTEN Trial
Antiviral Therapy, Vol. 16, Núm. 3, pp. 339-348
-
The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference
Journal of Viral Hepatitis, Vol. 18, Núm. SUPPL. 1, pp. 1-16
2010
-
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations
AIDS, Vol. 24, Núm. 7, pp. 1064-1066
-
Population pharmacokinetic modeling of the association between 63396C→T pregnane X receptor polymorphism and unboosted atazanavir clearance
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5242-5250
2009
-
When and how to use maraviroc in HIV-infected patients
AIDS, Vol. 23, Núm. 18, pp. 2377-2385
2005
-
Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations
AIDS Research and Human Retroviruses, Vol. 21, Núm. 6, pp. 555-559